Private Management Group Inc. lifted its position in shares of Enovis Corporation (NYSE:ENOV – Free Report) by 31.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,792,429 shares of the company’s stock after acquiring an additional 427,347 shares during the period. Private Management Group Inc.’s holdings in Enovis were worth $32,748,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also made changes to their positions in ENOV. Allworth Financial LP boosted its position in shares of Enovis by 59.7% during the 2nd quarter. Allworth Financial LP now owns 1,744 shares of the company’s stock worth $36,000 after acquiring an additional 652 shares in the last quarter. IFP Advisors Inc raised its position in Enovis by 5,590.5% during the second quarter. IFP Advisors Inc now owns 1,195 shares of the company’s stock valued at $25,000 after purchasing an additional 1,174 shares in the last quarter. Inspire Investing LLC raised its position in Enovis by 4.9% during the third quarter. Inspire Investing LLC now owns 34,833 shares of the company’s stock valued at $636,000 after purchasing an additional 1,631 shares in the last quarter. Amundi lifted its position in shares of Enovis by 2.3% during the 1st quarter. Amundi now owns 74,184 shares of the company’s stock worth $1,688,000 after buying an additional 1,677 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its holdings in shares of Enovis by 9.3% in the second quarter. Handelsbanken Fonder AB now owns 21,117 shares of the company’s stock worth $437,000 after acquiring an additional 1,800 shares during the last quarter. Institutional investors and hedge funds own 98.45% of the company’s stock.
Insider Activity at Enovis
In other Enovis news, insider Oliver Engert acquired 2,660 shares of the company’s stock in a transaction on Friday, September 4th. The shares were acquired at an average cost of $18.80 per share, with a total value of $50,008.00. Following the completion of the acquisition, the insider directly owned 63,898 shares in the company, valued at $1,201,282.40. This trade represents a 4.34% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Damien Mcdonald purchased 13,035 shares of the company’s stock in a transaction that occurred on Friday, September 4th. The shares were acquired at an average price of $19.15 per share, for a total transaction of $249,620.25. Following the completion of the purchase, the chief executive officer directly owned 247,077 shares in the company, valued at $4,731,524.55. This represents a 5.57% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have bought 23,293 shares of company stock valued at $449,599. 2.90% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on ENOV. Weiss Ratings upgraded Enovis from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, November 2nd. UBS Group restated a “buy” rating and issued a $44.00 price target on shares of Enovis in a research report on Monday, October 5th. Zacks Research upgraded Enovis from a “strong sell” rating to a “hold” rating in a research report on Wednesday, July 29th. Citigroup reissued a “market outperform” rating on shares of Enovis in a research note on Wednesday, September 2nd. Finally, Citizens Jmp reduced their price objective on Enovis from $55.00 to $47.00 and set a “market outperform” rating for the company in a research note on Wednesday, September 2nd. Ten investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $38.62.
View Our Latest Stock Report on Enovis
Enovis Trading Up 4.9%
Shares of ENOV stock opened at $28.48 on Tuesday. The company has a market capitalization of $1.64 billion, a price-to-earnings ratio of -3.09 and a beta of 1.31. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.00 and a current ratio of 1.98. The company has a 50-day simple moving average of $19.98 and a two-hundred day simple moving average of $23.11. Enovis Corporation has a 52-week low of $16.70 and a 52-week high of $32.41.
Enovis (NYSE:ENOV – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.77 by $0.11. Enovis had a positive return on equity of 12.03% and a negative net margin of 47.96%. The company had revenue of $558.73 million during the quarter, compared to the consensus estimate of $557.12 million. During the same period last year, the business posted $0.75 earnings per share. Enovis’s revenue was up 1.8% on a year-over-year basis. Research analysts anticipate that Enovis Corporation will post 3.15 EPS for the current fiscal year.
Enovis Company Profile
Enovis is a medical technology company that develops products and solutions for orthopedic care, surgery, recovery and rehabilitation. Its offerings include joint replacement implants, foot and ankle products, surgical instruments, orthopedic braces and supports, and rehabilitation equipment.
The company serves healthcare providers and patients in markets around the world. Its products are designed to support treatment across different stages of musculoskeletal care, from surgical intervention to recovery and mobility.
Enovis was formerly part of Colfax Corporation.
Read More
- Five stocks we like better than Enovis
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Want to see what other hedge funds are holding ENOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovis Corporation (NYSE:ENOV – Free Report).
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
